Chemical Synthesis of Highly Congested gp120 V1V2 N-Glycopeptide Antigens for Potential HIV-1-Directed Vaccines

Citations Over TimeTop 10% of 2013 papers

Abstract

Critical to the search for an effective HIV-1 vaccine is the development of immunogens capable of inducing broadly neutralizing antibodies (BnAbs). A key first step in this process is to design immunogens that can be recognized by known BnAbs. The monoclonal antibody PG9 is a BnAb that neutralizes diverse strains of HIV-1 by targeting a conserved carbohydrate-protein epitope in the variable 1 and 2 (V1V2) region of the viral envelope. Important for recognition are two closely spaced N-glycans at Asn(160) and Asn(156). Glycopeptides containing this synthetically challenging bis-N-glycosylated motif were prepared by convergent assembly, and were shown to be antigenic for PG9. Synthetic glycopeptides such as these may be useful for the development of HIV-1 vaccines based on the envelope V1V2 BnAb epitope.

Related Papers

• → Identification of Glycoproteins Containing Specific Glycans Using a Lectin-Chemical Method(2015)30 cited
• → An ultrafast and highly efficient enrichment method for both N-Glycopeptides and N-Glycans by bacterial cellulose(2020)13 cited
• → Protein glycosylation(1992)47 cited
• → Free glycans derived from glycoproteins present in human sera(2013)22 cited
• → Structures and Functions of Glycans in Glycoproteins.(2001)